Immunovations

We aim to develop the next generation of adjuvant for cancer vaccines that has proven superiority over traditional adjuvants in immune functionality assays.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Chicago, IL, US
  • Currency USD

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free